Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Old API Wind-down Ltd - Ordinary Shares ARLZQ

"Old API Wind-down Ltd, formerly Aralez Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in the acquisition, development, and commercialization of products primarily in cardiovascular, pain management and other specialty areas. Its key products include Fiorinal, Proferrin, Fibricor, Uracyst and Neovisc, Cambia and other marketed products. The company currently operates in two geographical markets, the United States and Canada. The firm generates most of its reven


OTCPK:ARLZQ - Post by User

Comment by GoldenDilemmaon Jun 22, 2016 1:46pm
70 Views
Post# 24988017

RE:RE:RE:Volume

RE:RE:RE:Volume
Bigboyone wrote: JFI- There are possibilites that we go into the $1.00-$2.00 Range.
I hope the bottom is $2.87-$3.10 Range as that puts us at $33-39 Cents.. For our Tribute /Stellar  (Pozen) shares,...anything below that is valueless to me..
I would be a big seller below those numbers.. Its almost as if we had a "Reverse Split" which is usually the kiss of death for a stock and company..
No Revenue and Yosprala delays, I dont see us going any higher from where we are until some really solid stuff comes to market.
It doesnt matter that Adams has some shares under water, hes getting paid and has tons of free shares too..



Giving a $1-$2 PT is a huge range. That may be a bit ambitious.
 
We hear from FDA very soon. This year has blasted by (albeit poor ARLZ performance) and Sept date is closer and closer. I suspect that if it is approved the sentiment will change. And who knows what is in store for M&A by years end. 

Director's have been filing purchases/ownership lately and it makes me wonder if things are being priced down here accordingly. 
<< Previous
Bullboard Posts
Next >>